ClearThink 1 Acquisition completes $125 million IPO on Nasdaq
ClearThink 1 Acquisition completes $125 million IPO on Nasdaq
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
Coinbase, Robinhood and Circle are expanding into stablecoins, payments and prediction markets, but their latest earnings show how hard it is to escape cry...
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse Articles
ClearThink 1 Acquisition completes $125 million IPO on Nasdaq
Production and supply dynamics tell the whole story here.
After-hours movers: MongoDB, Credo, SoFi Technologies and more
TD Securities' Reid Noch sees the exchange's tokenized-equities plan as a âEUR?"market structureâEUR moment, a sign that Wall Street is taking tokenizatio...
Bitfinex Securities will restart USDt-denominated bond issuances on BitcoinâEUR(TM)s Liquid Network, following four previous tokenized offerings totaling $...
Bitcoin just plunged toward $60,000, but price is not the only thing collapsing. Market sentiment has now dropped to one of the lowest levels ever recorded...
Crypto just pulled off a quiet comeback, fueling bullish Bitcoin price predictions.After weeks of steady bleeding, $1 billion suddenly flowed back into cry...
Claude had been gaining more respect with users following ChatGPT backlash and the introduction of new coding tools, though an outage might erode some of t...
Citi upgrades U.K. equities amid Middle East tensions âEUR" hereâEUR(TM)s why
These analysts see "limited" upside oil price risk amid Iran conflict. HereâEUR(TM)s why.
Coherent stock surges after Nvidia invests $2 billion
Intellia Therapeutics Shares Rise 4.8% as FDA Lifts Clinical Hold